Deutsche Bank
GBIO

Deutsche Bank’s Generation Bio GBIO Stock Holding History

Deutsche Bank’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-10,877
Closed -$44.6K – 3648
2025
Q1 		$44.6K Sell
10,877
-7,540
-41% -$53K ﹤0.01% 3394
2024
Q4 		$195K Buy
18,417
+16,082
+689% +$287K ﹤0.01% 3103
2024
Q3 		$57.7K Sell
2,335
-53,465
-96% -$1.41M ﹤0.01% 3338
2024
Q2 		$1.57M Sell
55,800
-69,357
-55% -$2.25M ﹤0.01% 1755
2024
Q1 		$5.09M Buy
125,157
+1,925
+2% +$45.3K ﹤0.01% 1268
2023
Q4 		$2.03M Buy
123,232
+121,312
+6,318% +$2.12M ﹤0.01% 1674
2023
Q3 		$72.8K Hold
1,920
– – ﹤0.01% 3299
2023
Q2 		$106K Sell
1,920
-998
-34% -$45.8K ﹤0.01% 3253
2023
Q1 		$125K Sell
2,918
-12,110
-81% -$586K ﹤0.01% 3219
2022
Q4 		$591K Buy
15,028
+1,032
+7% +$54.2K ﹤0.01% 2354
2022
Q3 		$743K Sell
13,996
-824
-6% -$51.5K ﹤0.01% 2152
2022
Q2 		$973K Sell
14,820
-438
-3% -$28.6K ﹤0.01% 2204
2022
Q1 		$1.12M Buy
15,258
+22
+0.1% +$1.27K ﹤0.01% 2272
2021
Q4 		$1.08M Sell
15,236
-501
-3% -$87.5K ﹤0.01% 2386
2021
Q3 		$3.95M Buy
15,737
+9
+0.1% +$2.15K ﹤0.01% 1649
2021
Q2 		$4.23M Buy
15,728
+941
+6% +$281K ﹤0.01% 1645
2021
Q1 		$4.21M Buy
14,787
+13,886
+1,541% +$4.44M ﹤0.01% 1652
2020
Q4 		$255K Buy
901
+245
+37% +$78.6K ﹤0.01% 3334
2020
Q3 		$202K Buy
+656
New +$157K ﹤0.01% 3209

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank's GBIO Position: Q2 2025 in Review

Deutsche Bank sold out of Generation Bio (GBIO) in Q2 2025, closing a stake of 10,877 shares — an estimated $44.6K sold.

Deutsche Bank first reported a position in GBIO in Q3 2020 and held it in 19 quarters. The position peaked at $5.09M in Q1 2024. 61 funds tracked by Wall St. Rank hold GBIO as of Q2 2025.

  • Deutsche Bank reported no remaining Generation Bio position as of Q2 2025 after selling out during the quarter.
  • Deutsche Bank sold 10,877 Generation Bio shares in Q2 2025, an estimated $44.6K.
  • Deutsche Bank first reported a position in Generation Bio in Q3 2020 and held it in 19 quarters.
  • Deutsche Bank's Generation Bio position peaked at $5.09M in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Generation Bio as of Q2 2025.

Based on Deutsche Bank's 13F filing for Q2 2025, filed 12 Aug 2025.